[et_pb_section fb_built=”1″ _builder_version=”3.22″ custom_padding=”3px|0px|54px|0px|false|false”][et_pb_row _builder_version=”3.25″ custom_margin=”|||” custom_padding=”15px||0||false|false”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/cdmocmo.ribobio.com\/wp-content\/uploads\/2018\/10\/about_us.jpg” align_tablet=”center” align_last_edited=”on|desktop” _builder_version=”3.23″ custom_margin=”||15px|”][\/et_pb_image][et_pb_text _builder_version=”3.26.8″ custom_margin=”||10px|” custom_padding=”|||”]<\/p>\n
RiboBio is Asia\u2019s largest oligonucleotide-based drug manufacturer. Over the years, RiboBio has developed many novel nucleic-acid based technologies utilizing its world-class R&D team equipped with state-of-the-art tools and facilities. Currently, RiboBio develops and supplies innovative RNAi, lncRNA and miRNA products and offers as diverse line of oligonucleotide-based services including CRO, Synthesis and CDMO services from small to commercial scales. Our customers represent thousands from academia, medical, pharmaceutical, industrial and government organizations, both domestic and international.<\/p>\n
RiboBio was the first licensed cGMP manufacturing facility in China specializing in Oligonucleotide Manufacturing. In its facilities, RiboBio offers a wide-range of synthesis scales for oligonucleotides, from milligram to multi-kilogram, with diverse modifications and chemistries. RiboBio manufactures oligonucleotides for various purposes including; pre-clinical research and toxicology studies, to clinical trials from Phase I to Phase III, and marketed-product commercialization of final API, diagnostic or cosmetic ingredient. To assure the success of our manufacturing projects, we work closely with our clients: from the definition of the projects initial goals through development, including analytical methods development, tox and stability studies, through commercialization and beyond.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”3.25″ custom_margin=”20px|||” custom_padding=”0px|0px|0|0px|false|false”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text _builder_version=”3.26.8″ text_font=”||||||||” text_font_size=”16px”]<\/p>\n
Honors<\/b><\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_id=”honour-box” _builder_version=”3.25″ custom_padding=”0|0px|27px|0px|false|false” column_structure=”1_4,1_4,1_4,1_4″][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb image=”https:\/\/cdmocmo.ribobio.com\/wp-content\/uploads\/2018\/08\/company-honour5.jpg” _builder_version=”3.26.8″ custom_margin=”10px|0px|0px|0px” custom_padding=”0px|0px|0px|0px” locked=”off”]<\/p>\n
Key high-tech enterprise of National Torch Program<\/p>\n
[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb image=”https:\/\/cdmocmo.ribobio.com\/wp-content\/uploads\/2018\/08\/honour2.jpg” _builder_version=”3.26.8″ custom_margin=”10px|0px|0px|0px” custom_padding=”0px|0px|0px|0px”]<\/p>\n
Engineering Technology Center for Oligonucleotide-based Drugs<\/p>\n
[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb image=”https:\/\/cdmocmo.ribobio.com\/wp-content\/uploads\/2018\/08\/company-honour3.jpg” _builder_version=”3.26.8″ custom_margin=”10px|0px|0px|0px” custom_padding=”0px|0px|0px|0px”]<\/p>\n
Translational Medicine Cooperation Base<\/p>\n
[\/et_pb_blurb][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_blurb image=”https:\/\/cdmocmo.ribobio.com\/wp-content\/uploads\/2018\/08\/honour.jpg” _builder_version=”3.26.8″ custom_margin=”10px|0px|0px|0px” custom_padding=”0px|0px|0px|0px”]<\/p>\n
Oligonucleotide API production license<\/p>\n
[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
[et_pb_section fb_built=”1″ _builder_version=”3.22″ custom_padding=”3px|0px|54px|0px|false|false”][et_pb_row _builder_version=”3.25″ custom_margin=”|||” custom_padding=”15px||0||false|false”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_image src=”https:\/\/cdmocmo.ribobio.com\/wp-content\/uploads\/2018\/10\/about_us.jpg” align_tablet=”center” align_last_edited=”on|desktop” _builder_version=”3.23″ custom_margin=”||15px|”][\/et_pb_image][et_pb_text _builder_version=”3.26.8″ custom_margin=”||10px|” custom_padding=”|||”] RiboBio is Asia\u2019s largest oligonucleotide-based drug manufacturer. Over the years, RiboBio has developed many novel nucleic-acid based technologies utilizing its world-class R&D team equipped with state-of-the-art tools and facilities. Currently, RiboBio develops and supplies innovative RNAi, […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":121,"comment_status":"closed","ping_status":"closed","template":"page-hsy.php","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"_links":{"self":[{"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/pages\/21519"}],"collection":[{"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/comments?post=21519"}],"version-history":[{"count":7,"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/pages\/21519\/revisions"}],"predecessor-version":[{"id":22076,"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/pages\/21519\/revisions\/22076"}],"wp:attachment":[{"href":"https:\/\/cdmocmo.ribobio.com\/en\/wp-json\/wp\/v2\/media?parent=21519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}